Christina A. Harrington

Author

Also Known As

C. A. HARRINGTON, C. A. Harrington, C. Harrington, Christina A Harrington, Christina A. Harrington, Christina Harrington, Harrington, Christina A.

104

Publications

3.9K

Citations

H-Index

103

Concepts

All Affiliations

Oregon Health & Science University Igenbio (United States)Legacy Health University of California San Diego Portland VA Medical Center

About

Christina A. Harrington is an author at Oregon Health & Science University specializing in medicine, gene expression, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	1.3K
2	Health Sciences	3	3	224
3	Engineering	2	2	30
4	Natural Sciences	2	2	32
5	Public Health	2	2	86

Christina A. Harrington

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Analysis of high density expression microarrayswith signed-rank call algorithms Wei-min Liu, Rui Mei, X. Di, Bioinformatics	2002	422
Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states Mary P. Stenzel‐Poore, Susan L. Stevens, Zhi‐Gang Xiong, The Lancet Cerebral Vascular RegulationNeurophysiologyMedicinePhysiologyHypoxia (Medicine)	2003	393
Systemic Lipopolysaccharide Protects the Brain from Ischemic Injury by Reprogramming the Response of the Brain to Stroke: A Critical Role for IRF3 B. J. Marsh, Susan L. Stevens, Amy E.B. Packard, Journal of Neuroscience	2009	228
Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays Brian K. Dieckgraefe, William F. Stenson, Josh Korzenik, Physiological Genomics InflammationFunctional GenomicsAutoimmune DiseaseParallel Oligonucleotide ArraysMucosal Immunology	2000	183
AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB Noah I. Hornick, Ben Doron, Sherif Abdelhamed, Science Signaling ImmunologyPathologyAml ExosomesTumor BiologyMyeloid Neoplasia	2016	150
A gene expression signature of CD34+ cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib Shannon K. McWeeney, Lucy Pemberton, Marc Loriaux, Blood	2009	128
MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer’s Disease Theresa A. Lusardi, Jay I. Phillips, Jack Wiedrick, Journal of Alzheimer s Disease	2016	120
microRNA‐130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO‐1 Xiaowei Chen, Min Zhao, Jin Huang, Journal of Cellular Biochemistry	2018	100
Analysis of extracellular RNA in cerebrospinal fluid Julie A. Saugstad, Theresa A. Lusardi, Kendall Van Keuren‐Jensen, Journal of Extracellular Vesicles	2017	95
Hypothesis: Sarcoidosis is a STAT1-mediated disease James T. Rosenbaum, Sirichai Pasadhika, Elliott D. Crouser, Clinical Immunology InflammationPulmonary PathologyAutoimmune DiseaseDisease MechanismPathogenesis	2009	92

Page 1